Director Omnibus Decision – 19 IPRsOctober 21, 2026
Notice of Decisions on Institution — 2026-10-21
Patent Trial and Appeal Board
Total Proceedings
19
in this notice
Total Denied
2
discretionary + merits
Total Instituted
3
trial granted
Grant Rate
60%
40% denial rate
Trial Instituted· 3 proceedings
IPR2026-00358IPR2026-00374IPR2026-00316
Discretionary Denial· 2 proceedings
IPR2026-00263IPR2026-00375
Referred for merits review· 14 proceedings
IPR2026-00341IPR2026-00380IPR2026-00407IPR2026-00376IPR2026-00381PGR2026-00059IPR2026-00377IPR2026-00382PGR2026-00060IPR2026-00378IPR2026-00397PGR2026-00061IPR2026-00379IPR2026-00400
Note
The USPTO Director issued an omnibus institution notice covering multiple proceedings. Written opinions may follow for selected cases. After review of discretionary considerations, 14 proceedings will be reviewed for merits and non-discretionary considerations; their institution decisions will come in a later notice.
New to PTAB and post-grant? Start with IPR vs. PGR: Inter Partes Review and Post-Grant Review Compared
- PTAB Director Review · Oct. 21, 2026Palo Alto Networks, Inc. v. Qomplx LLC
- PTAB Director Review · Oct. 19, 2026Notice of Decisions on Institution — 2026-10-19
- PTAB Director Review · Oct. 8, 2026Notice of Decisions on Institution — 2026-10-08
- PTAB Director Review · Sept. 24, 2026Biocon Biologics Limited et al. v. Regeneron Pharmaceuticals, Inc.
- PTAB Director Review · Sept. 23, 2026Notice of Decisions on Institution — 2026-09-23